#RespiratoryCareDevices

[metastatblog]

Respiratory Care Devices Market Analysis, Size, Share, Growth, Trends, and Forecasts by 2031

The Global Respiratory Care Devices market stands as a cornerstone within the healthcare industry,  providing essential tools and technologies to support individuals afflicted with respiratory ailments. 

𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.metastatinsight.com/request-sample/2640

Top Companies

Drägerwerk AG & Co. KGaA 

Fisher & Paykel Healthcare Limited. 

General Electric Company 

Getinge AB 

Inogen, Inc.

Masimo. 

Medtronic 

Koninklijke Philips N.V.

ResMed 

VYAIRE. 

3B Medical Inc. 

Airon Corporation 

alpha trace medical systems

APEX MEDICAL CORP.

Besco Medical

This industry encompasses a diverse array of devices designed to aid in the diagnosis, treatment, and  management of respiratory disorders, ranging from chronic conditions like asthma and chronic  obstructive pulmonary disease (COPD) to acute respiratory distress syndrome (ARDS) and  respiratory failure. 

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:@https://www.metastatinsight.com/report/respiratory-care-devices-market

The Global Respiratory Care Devices market is driven by the pressing need to address the growing  prevalence of respiratory diseases worldwide. Factors such as pollution, smoking, aging populations,  and lifestyle changes contribute to the rising incidence of respiratory disorders, prompting an  increased demand for innovative respiratory care solutions. As a result, the industry continuously  evolves to meet the evolving needs of patients and healthcare providers alike. 

Moreover, the Global Respiratory Care Devices market encompasses a range of monitoring and  consumable products essential for ongoing respiratory care. Pulse oximeters, capnographs, and  respiratory rate monitors enable continuous monitoring of patients' respiratory status, facilitating  timely interventions and adjustments to treatment protocols. Additionally, consumables such as  oxygen masks, tubing, and filters are integral components of respiratory care delivery, ensuring the  safe and effective operation of therapeutic devices. 

In recent years, technological advancements have propelled innovation within the Global  Respiratory Care Devices market, leading to the development of more efficient and user-friendly  solutions. Miniaturization, wireless connectivity, and integration with digital health platforms have  enhanced the accessibility and effectiveness of respiratory care devices, empowering patients to  actively participate in self-management and remote monitoring of their conditions. 

Furthermore, the COVID-19 pandemic has underscored the critical importance of respiratory care  devices in managing respiratory distress and supporting patients with severe respiratory  complications. The surge in demand for ventilators, oxygen therapy equipment, and airway  clearance devices during the pandemic highlighted the indispensable role of the respiratory care  industry in safeguarding public health and saving lives. 

The Global Respiratory Care Devices market is a dynamic and indispensable sector within the  healthcare industry, dedicated to addressing the complex needs of individuals with respiratory  disorders. By providing innovative diagnostic, therapeutic, and monitoring solutions, this industry  plays a vital role in improving patient outcomes, enhancing quality of life, and advancing respiratory  health on a global scale.  

Global Respiratory Care Devices market is estimated to reach $41529.0 Million by 2031; growing at a  CAGR of 7.9% from 2024 to 2031.

Contact Us:   

inquiry@metastatinsight.com

+1 214 613 5758

[healthcare-industry-research]

Rising demand for enhanced portable and compact respiratory care devices, key players focusing on expanding their geographical reach, rising demand for multimodal ventilation, and the rising adoption of non-invasive ventilation are the key trends in market.

[healthcare-industry-research]

Respiratory Care Devices Market - Emerging Technologies | Forthcoming Industry Trends | Global Future Forecasts

The study involved 4 major activities in estimating the current market size for the respiratory care devices market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. Recent Developments:

In May 2019, Fisher Paykel (New Zealand) launched a nasal cannula - F&P Optiflow 3S, to strengthen its position in the therapeutic respiratory care devices market.

In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.

In March 2018, Philips opened its first Sleep and Respiratory Education Center in Singapore.

In May 2019 Masimo Corporation (US) signed an agreement with Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) to offer Masimo SET Measure-through Motion and Low Perfusion pulse oximetry in its monitoring devices. Mindray devices equipped with SET will now be available in select countries in Europe, the Middle East, Russia, the Commonwealth of Independent States, and the Asia Pacific (excluding China), including Australia and India.

Expected Revenue Generation: The respiratory care devices market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1%. Looking out for More Details | Download the PDF Brochure Major Factors Influencing the Global Industry Growth: The major factor driving the growth of the respiratory care devices market is the high prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population, high prevalence of tobacco smoking, urbanization and growing levels of pollution, and changing lifestyles. However, factors such as the presence of an unfavorable reimbursement scenario and the availability of low-cost products from local manufacturers are expected to restrain the growth of this market during the forecast period. Industry Leaders and Growth Strategies Adopted by Them: The respiratory care devices market is fragmented in nature, with the top five players accounting for around half of the total market in 2018. There are other smaller and medium-sized players as well, operating at both global and regional levels. The leading market players are based across developed countries such as the US, the Netherlands, New Zealand, and Ireland; however, in the past few years, smaller players have emerged, especially in the Asia Pacific market, competing with global players on the basis of price. Lucrative growth opportunities in the Asia Pacific market are increasing competition among market players. Companies are also focusing on R&D to add innovative technologies and products to their portfolios, which, in turn, helps them to strengthen their presence in respective markets. Some of the other leading players competing in this market are Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Chart Industries (US), Drager AG (Germany), Invacare Corporation (US), Getinge AB (Sweden), Air Liquide (France), Hamilton Medical AG (Switzerland), Vyaire Medical (US), GE Healthcare (US), Nonin Medical Inc. (US), Apex Medical Corp. (Taiwan), Smiths Group (UK), Omron Healthcare Inc. (US), Allied Healthcare Products, Inc. (US), Teleflex Incorporated (US), and DeVilbiss Healthcare LLC (US). Read More@ https://www.marketsandmarkets.com/PressReleases/respiratory-care-devices.asp

[healthcare-industry-research]

Respiratory Care Devices Market - Current & Emerging Trends | Global Industry Future Forecasts

https://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.htmlA number of factors such as high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes are fueling the growth of Respiratory Care Devices Market.  However, the lack of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market. Growth in elderly population to drive the demand for respiratory care therapeutic devices during the forecast period Therapeutic devices are used to treat respiratory ailments, which are caused due to trauma, obstructive sleep apnea (OSA), COPD, and other respiratory conditions. The growing elderly population around the globe is expected to increase the demand for respiratory therapeutic devices in the coming years. This is an important indicator for market growth as the risk of chronic diseases increases with age. For instance, in the geriatric population, the prevalence rate of chronic diseases is 64 per 1,000 individuals. According to the UN, it is estimated that the global elderly population (60 years or above) will reach 2.10 billion by 2050 from 0.96 billion in 2017. The geriatric population in the European region increased from 16.3% in 2010 to 19.8% in 2017 and is further expected to reach 22.4% by 2030. Growth in the elderly population is expected to drive the demand for therapeutic devices, such as nebulizers, oxygen concentrators, humidifiers, and PAP devices. Asia pacific showcase high growth potential for the Respiratory Care Devices Market Countries in the APAC region, such as China and India have shown remarkable economic growth in the past decade, and are likely to surpass many developed countries in the coming years. Although, the healthcare industry in these countries still follows a traditional model of healthcare delivery; the situation is gradually changing with growing health awareness, increasing demand for better healthcare services, and increasing penetration of newer technologies. Get 10% Free Customization on This Report@ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=368 In developing regions, the rate of preterm births is as high as 25%. According to the WHO, around 60% of preterm births occur in Africa and South Asia, with India and China reporting the highest number of preterm births. Large population of preterm birth with rising healthcare expenditure in the emerging economies is further expected to drive the market for respiratory care devices in the region. Traditionally, in terms of technology, the medical industry in the APAC region has followed trends in North American and European markets. However, the medical devices industry in this region has grown significantly over the years and manufacturers are now beginning to focus on providing advanced technologies to ensure sustainable and strong future growth in this region. Philips Healthcare (The Netherlands), ResMed, Inc. (U.S.), Medtronic plc (Ireland), Masimo Corporation (U.S.), and Fisher & Paykel Healthcare Corporation Limited (New Zealand) held the major share of the respiratory care devices market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are Becton, Dickinson and Company (U.S.), Chart Industries, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).  Read More@  https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

[healthcare-industry-research]

Respiratory Care Devices Market by Type, Disease & End Users

The major factors driving the growth of this Respiratory Care Devices Market include high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes.

The rapid developments in emerging markets such as Asia-Pacific and Latin America and the growing demand for point-of-care (POC) diagnostic devices are expected to provide significant growth opportunities for players operating in the respiratory care devices market in the coming years.

The rising demand for enhanced portable devices, growing demand for multimodal ventilators and focus of market players on expanding their geographic presence are the key trends of this market. However, the lack of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market.

Read More Details | Get the Sample Pages@ http://bit.ly/2A30Rsr

This market is segmented on the basis of type, disease/disorder, end user and regions. Based on type, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. The therapeutic devices segment is sub segmented into PAP devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods. The monitoring devices segment is sub segmented into pulse oximeters, capnographs and gas analyzers.

The diagnostic devices segment is sub segmented into spirometers, polysomnography devices (PSG), peak flow meters and other diagnostic devices. The consumables and accessories segment is subsegmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas and other consumables and accessories. In 2015, therapeutic devices accounted for the largest share of the global respiratory care devices type market. The rising incidence of chronic diseases and growing geriatric population contributes to their largest share in respiratory care devices type market.

Based on disease/disorder, the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other diseases/disorders. The other diseases/disorders segment includes lung cancer, pulmonary fibrosis, pulmonary embolism, cystic fibrosis, and allergies. In 2015, COPD accounted for the largest share of the global respiratory care devices market, by disease/disorder. The factors contributing to the growth of this technology segment includes increasing tobacco smoking prevalence and rising pollution levels globally.

Furthermore, on the basis of end users, the market is classified into hospitals, home care and ambulatory care. The hospitals companies segment accounted for the largest share in the global respiratory care devices market, by end users. The factors contributing to the growth of this end user segment includes the financial capabilities of hospitals to purchase high-priced instruments as well as the availability of trained professionals in hospitals to operate respiratory care devices.

You Can Also Request to Get 10% FREE Customization on This Report

In 2015, North America accounted for the largest share of the global respiratory care devices market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the rising geriatric population, the presence of a well-established healthcare industry, availability of life sciences and medical research funding, rising geriatric population, growing demand for point-of-care diagnostic testing, and increasing government healthcare expenditure.

As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. The rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, low labor costs, favorable regulatory environment and expansion of private-sector hospitals to rural areas in various APAC and Latin American countries are some factors that will fuel the growth of respiratory care devices market in these regions.

The global respiratory care devices market is fragmented, with the presence of many small and medium-size companies which operate in their respective market segments. In order to maintain their market shares, leading players in the market are continuously developing new technologies and upgrading their existing products to enhance their product portfolios. Some of the prominent players in the global market include Philips Healthcare (The Netherlands), ResMed Inc. (U.S.), Medtronic plc (Ireland), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), Becton, Dickinson and Company (U.S.), Chart Industries, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).

Target Audience:

Respiratory care device manufacturers and distributors

Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

Research institutes

Contract manufacturing organizations (CMOs)

Government associations

Market research and consulting firms

Venture capitalists and investors

Read More@ https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html